Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
  • Primary Care
  • Contact hours
$25.00
1.25 NAPNAP Contact Hour of which contains 0.25 pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non- members, this continuing education activity rate is $25. Alarmed about increasing numbers of young people contemplating or attempting suicide? Need to expand your knowledge of youth suicidality? This session will provide an overview of the epidemiology of youth suicide, and present evidenced-based approaches to preventing this tragic loss of young life. Related health equity and social determinant of health issues, including lethal means reduction will be discussed. The session will also introduce the Alliance to Prevent Youth Suicide, a new five year initiative supported by NAPNAP Partners for Vulnerable Youth. Attendees of this session will leave with increased knowledge, tools and resources to assist in addressing this critical issue.
  • Primary Care
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour of which contains 0.25 pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Diabetes is a chronic condition that requires intensive medical and psychological management with rapidly rising prevalence in the U.S. The most common form of pediatric diabetes is type 1 diabetes, affecting 1.25 million children who are two to four times more likely to have other autoimmune conditions including Hashimoto's thyroiditis, celiac disease and adrenal insufficiency than the general population. Timely screenings as recommended by the American Diabetes Association and proper assessment is key to identifying comorbidities and preventing both diabetes related complications as well as treating associated endocrine pathologies including those that can be potentially life threatening. This case-based, interactive presentation will provide pediatric advanced practice providers with robust clinical pearls on recognizing and managing endocrine disorders commonly seen in patients with diabetes mellitus, type 1.
  • Primary Care
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour of which contains 1.00 pharmacology, 1.00 Controlled Substances and 0.25 Psychopharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. The American Academy of Pediatrics recommends medication assisted treatment for adolescents with opioid use disorders (MOUD) but less than 12% of affected youth ever receive treatment and even fewer receive MOUD. In an effort to get evidence-based treatment to people with OUD, in 2021 the HHS relaxed the laws that govern MOUD prescribing. Similar to collaborative care approaches to treatment of other mental health disorders, pediatric-focused NPs should be the first person their patients look to for helping them recover from OUDs. This case-based presentation will give participants an overview of screening and evidence-based treatment for youth with OUDs, followed by practical advice and resources for preparing a practice to care for this population.
  • Primary Care
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour of which contains 0.25 pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This session will discuss the NAEPP Focused Update to the Asthma Management Guidelines. The presenter will discuss the use of single maintenance and reliever therapy (SMART) for children and practice implications for nurse practitioners. The presentation will include case studies and encourage audience participation.
  • Primary Care
  • Contact hours
$25.00
1.25 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non- members, this continuing education activity rate is $25. This presentation will review current, state of the art treatments for ADHD including the eight new drugs approved since 2015. We will also discuss treating ADHD in the presence of neurologic comorbidities such as tics, anxiety and autism when access to pediatric psychiatrists and behavioral health specialists is becoming more difficult in the era of COVID.
  • Primary Care
  • Contact hours
$25.00
1.25 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non- members, this continuing education activity rate is $25. This presentation will cover a multitude of neurological symptoms that almost always present to primary care providers in outpatient setting. We will review common complaints such as headache, toe walking, abnormal movements, vomiting and more as we journey the history taking process to recognize red flags and prompt referral to specialty care. Using case-based examples, you will learn why early hand preference may indicate stroke and why a teen girl with migraines may be presenting with a thrombosis.
  • Primary Care
  • Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. Cerebral palsy (CP) is the most common childhood disability. Given the prevalence, pediatric providers should be trained in early recognition and appropriate interventions for children diagnosed with CP. This presentation will discuss up to date recommendations and review evidence-based guidelines for multiple developmental domains including motor, cognitive, communication, eating/drinking, vision, sleep, tone and musculoskeletal.
  • Primary Care
  • FREE for Members
  • Pharmacology CE
  • Contact hours
$10.00
1.0 NAPNAP contact hour, 1.0 pharmacology contact hour. This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. Before 2018, there were no U.S. Food and Drug Administration approved medications for managing seizures in Dravet syndrome (DS). Common agents used in the antiepileptic drug regimens of patients with DS included clobazam, valproic acid, topiramate, and levetiracetam, among others; however, these agents alone rarely provide adequate seizure control. Management of seizures in DS changed in recent years with the approval of cannabidiol and stiripentol in 2018 and fenfluramine in 2020. This continuing education article summarizes available efficacy and safety data involving cannabidiol, stiripentol, and fenfluramine and provides a practical review of dosing strategies, pharmacokinetics, and monitoring interventions relevant to their use. J Pediatr Health Care. (2022) 36, 479−488
  • Primary Care
  • FREE for Members
  • Contact hours
$10.00
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. The gynecologic assessment in prepubertal children is an essential element of a thorough physical examination. It is not unusual for pediatric health care providers, including pediatric nurse practitioners (PNPs), to feel challenged by assessing for gynecologic signs and symptoms and performing a physical examination of the external genitalia in prepubertal girls (Bhoopatkar, Wearn, & Vnuk, 2017; Dabson, Magin, Heading, & Pond, 2014; McBain, Pullon, Garrett, & Hoare, 2016). The benefits of routine genital examinations have been discussed in the literature, including increasing patient and caregiver comfort with an examination, improved health care provider skill and confidence with examination and diagnostic assessment, providing a baseline for future examinations, and documentation of previously undiscovered anomalies (Johnson, 2002). This continuing education article will discuss genital examination preparation and techniques, normal prepubertal hymenal variants, common prepubertal gynecologic problems, and genital examination findings concerning abuse. J Pediatr Health Care. (2022) 36, 489-499
  • Primary Care
  • FREE for Members
  • Contact hours
$10.00
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Eating disorders are complex, potentially life-threatening conditions characterized by disruptive eating behaviors that significantly impact physical and psychosocial functioning. Eating disorders are associated with devastating medical complications and high mortality rates if left untreated. As the prevalence of eating disorders among adolescents continues to increase, it is important that clinicians are knowledgeable about early signs of disordered eating and facilitate timely evaluation and care coordination. The epidemiology, risk factors, and medical complications for common eating disorders in primary care such as anorexia nervosa, bulimia nervosa, and binge eating disorder, are presented. An approach to screening for eating disorders, clinical assessment, and treatment options are outlined. J Pediatr Health Care. (2022) 36, 618−627.

Pages